If we build it, will they come? Exploring feasibility of community pharmacy diabetes care services
Corresponding Author
Wesley Nuffer Pharm.D.
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, Colorado, USA
Correspondence
Wesley Nuffer, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, 12850 E. Montview Boulevard, Mail Stop C238, Aurora, CO 80045, USA.
Email: [email protected]
Search for more papers by this authorDeborah Gallegos Pharm.D.
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, Colorado, USA
Search for more papers by this authorAndrea Segerstrom-Nunez Pharm.D.
Good Day Pharmacies, Loveland, Colorado, USA
Search for more papers by this authorKelsey Schwander Pharm.D.
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, Colorado, USA
Search for more papers by this authorCorresponding Author
Wesley Nuffer Pharm.D.
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, Colorado, USA
Correspondence
Wesley Nuffer, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, 12850 E. Montview Boulevard, Mail Stop C238, Aurora, CO 80045, USA.
Email: [email protected]
Search for more papers by this authorDeborah Gallegos Pharm.D.
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, Colorado, USA
Search for more papers by this authorAndrea Segerstrom-Nunez Pharm.D.
Good Day Pharmacies, Loveland, Colorado, USA
Search for more papers by this authorKelsey Schwander Pharm.D.
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, Colorado, USA
Search for more papers by this authorAbstract
Pharmacists have been well established for their role in diabetes care services, both in improving patient health outcomes as well as decreasing overall costs of care. The community pharmacy environment is currently challenging, and there are efforts to transform these practices to become more patient-centered. There are two standardized programs, the diabetes self-management education and support program and the national diabetes prevention program, that are available for pharmacists to deliver in the community setting. These programs offer some revenue generation for services but pose some challenges in their delivery as well. Exploring facilitators and barriers to these programs, and to diabetes care services in general, with a focus on community pharmacy practice, is important. Revenue generation needs to offset personnel cost and justify the resources dedicated to expand community practice beyond traditional dispensing. Further payer reform, likely with integrating medical billing, is essential for further progress to be made in this area.
CONFLICT OF INTEREST STATEMENT
The authors declare no conflicts of interest.
Open Research
DATA AVAILABILITY STATEMENT
Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
REFERENCES
- 1Adams M, Blouin R. The role of the pharmacist in health care: expanding and evolving. NC Med J. 2017; 78(3): 165–167.
- 2Koehler T, Brown A. Documenting the evolution of the relationship between the pharmacy support network and pharmacists to support patient care. Res Soc Admin Pharm. 2017; 13: 280–285. https://doi.org/10.1016/j.sapharm.2016.10.012
- 3Bai S, Hertig J, Weber R. Nontraditional career opportunities for pharmacists. Hosp Pharm. 2016; 51(11): 944–949. https://doi.org/10.1310/hpj5111-944
- 4Giannitrapani K, Glassman P, Vang D, McKelvey JC, Day RT, Dobscha SK, et al. Expanding the role of clinical pharmacists on interdisciplinary primary care teams for chronic pain and opioid management. BMC Fam Pract. 2018; 19(107): 107. https://doi.org/10.1186/s12875-018-0783-9
- 5Fitzpatrick K, Allen E, Griffin B, O'Shea JP, Dalton K, Bennett-Lenane H. Exploring career choices of pharmacy graduates over 15 years: a cross-sectional evaluation. Curr Pharm Teach Learn. 2024; 16(5): 307–318. https://doi.org/10.1016/j.cptl.2024.02.010
- 6Isenor J, Cossette B, Murphy A, Breton M, Mathews M, Moritz LR, et al. Community pharmacists' expanding roles in supporting patients before and during COVID-19: an exploratory qualitative study. Int J Clin Pharmacol. 2023; 45(1): 64–78. https://doi.org/10.1007/s11096-022-01430-7
- 7Mossialos E, Naci H, Courtin E. Expanding the role of community pharmacists: policymaking in the absence of policy-relevant evidence? Health Policy. 2013; 111(2): 135–148. https://doi.org/10.1016/j.healthpol.2013.04.003
- 8Mossialos E, Courtin E, Naci H, Benrimoj S, Bouvy M, Farris K, et al. From diabers to health care providers: transforming the role of community pharmacists in chronic disease management. Health Policy. 2015; 119(5): 628–639. https://doi.org/10.1016/j.healthpol.2015.02.007
- 9Gabay M. Direct and indirect remuneration fees: the controversy continues. Hosp Pharm. 2017; 52(11): 740–741. https://doi.org/10.1177/0018578717739633
- 10Salako A, Ullrich F, Mueller K. Financial issues challenging sustainability of rural pharmacies. Am J Med Res. 2017; 4(2): 147–161.
10.22381/AJMR4220176 Google Scholar
- 11Reisetter B, Dunson D, Kolassa EM, Schwab P. CPMM policy report: effect of Medicare part D reimbursement on community pharmacy profitability. Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, Oxford. https://www.drake.edu/deltarx/innovativeresources/articles/other/effectofmedicarepartdreimbursementoncommunitypharmacyprofitability/ (2007) Accessed 27 Aug 2024
- 12Siu A, Krass I, Mitchell B, McNamara K. Implementation of diabetes screening in community pharmacy – factors influencing successful implementation. Res Soc Admin Pharm. 2021; 17(9): 1606–1613. https://doi.org/10.1016/j.sapharm.2020.12.013
- 13 Centers of Disease Control and Prevention. National diabetes statistics report. https://www.cdc.gov/diabetes/php/data-research/index.html (2024). Accessed 27 Aug 2024
- 14Oprinovich S. Pharmacists raise the alarm about staffing, workload. Pharm Times. Pharmacy faculty interview. https://www.pharmacytimes.com/view/pharmacists-raise-the-alarm-about-staffing-workload (2023). Accessed 27 Aug 2024
- 15Katangwe T, Family H, Sokhi J, Kirkdale CL, Twigg MJ. The community pharmacy setting for diabetes prevention: a mixed methods study in people with ‘pre-diabetes’. Res Soc Admin Pharm. 2020; 16(8): 1067–1080. https://doi.org/10.1016/j.sapharm.2019.11.001
- 16Ip EJ, Shah BM, Yu J, Chan J, Nguyen LT, Bhatt DC. Enhancing diabetes care by adding a pharmacist to the primary care team. Am J Health-Syst Pharm. 2013; 70(10): 877–886. https://doi.org/10.2146/ajhp120238
- 17Yu J, Shah BM, Ip EJ, Chan J. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente northern California. J Manag Care Pharm. 2013; 19(2): 102–114. https://doi.org/10.18553/jmcp.2013.19.2.102
- 18Fera T, Bluml BM, Ellis WM. Diabetes Ten City challenge: final economic and clinical results. J Am Pharm Assoc. 2009; 49(3): 383–391. https://doi.org/10.1331/JAPhA.2009.09015
- 19Lopez T, Nuffer W. Impact and sustainability of a 10-year community pharmacy disease management service. Innov Pharm. 2021; 12(1): 1-7. https://doi.org/10.24926/iip.v12i1.3630
10.24926/iip.v12i1.3630 Google Scholar
- 20Meade LT, Tart RC, Buzby HL. Evaluation of diabetes education and pharmacist interventions in a rural, primary care setting. Diabetes Spectr. 2018; 31(1): 90–95. https://doi.org/10.2337/ds16-0064
- 21Nuffer W, Trujillo T, Griend JV. Estimated potential financial impact of pharmacist-delivered disease management services across a network of pharmacies in rural Colorado. J Manag Care Spec Pharm. 2019; 25(9): 984–988. https://doi.org/10.18553/jmcp.2019.25.9.984
- 22Presley B, Groot W, Pavlova M. Pharmacy-led interventions to improve medication adherence among adults with diabetes: a systematic review and meta-analysis. Res Social Adm Pharm. 2019; 15(9): 1057–1067. https://doi.org/10.1016/j.sapharm.2018.09.021
- 23Choe HM, Mitrovich S, Dubay D, Hayward RA, Krein SL, Vijan S. Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am J Manag Care. 2005; 11(4): 253–260.
- 24Fitch K, Pyenson BS, Iwasaki K. Medical claim cost impact of improved diabetes control for medicare and commercially insured patients with type 2 diabetes. J Manag Care Pharm. 2013; 19(8): 609–620, 620a–620d. https://doi.org/10.18553/jmcp.2013.19.8.609
- 25Roszak SE, Ferreri SP. Community pharmacy engagement in diabetes prevention: key informant interviews with pharmacy executives. Prev Chronic Dis. 2020; 20(17): E90. https://doi.org/10.5888/pcd17.200050
10.5888/pcd17.200050 Google Scholar
- 26Richard C, Urick B, Pathak S, Jackson J, Livet M. Performance-based pharmacy payment models: key components and critical implementation considerations for successful uptake and integration. J Manag Care Spec Pharm. 2021; 27(11): 1568–1578. https://doi.org/10.18553/jmcp.2021.27.11.1568
- 27Nguyen E, Walker K, Adams J, Wadsworth T, Robinson R. Reimbursement for pharmacist-provided health care services: a multistate review. J Am Pharm Assoc. 2021; 61(1): 27–32. https://doi.org/10.1016/j.japh.2020.09.009
- 28Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346(6): 393–403. https://doi.org/10.1056/NEJMoa012512
- 29Powers MA, Bardsley J, Cypress M, Duker P, Funnell MM, Fischl AH, et al. Diabetes self-management education and support in type 2 diabetes: a joint position statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics. Clin Diabetes. 2016; 34(2): 70–80. https://doi.org/10.2337/diaclin.34.2.70
- 30 Centers for Disease Control and Prevention. Registry of all recognized organizations. https://dprp.cdc.gov/Registry. Accessed 27 Aug 2024
- 31 American Diabetes Association. Find a diabetes education program. https://diabetes.org/tools-resources/diabetes-education-programs. Accessed 27 Aug 2024
- 32 Association of Diabetes Care and Education Specialists. Find diabetes education & support programs. https://www.adces.org/program-finder. Accessed 27 Aug 2024
- 33Valliant S, Burbage S, Pathak S, Urik B. Pharmacists as accessible health care providers: quantifying the opportunity. J Manag Care Spec Pharm. 2022; 28(1): 85–90. https://doi.org/10.18553/jmcp.2022.28.1.85
- 34Pierce K, White L, Keedy C. Utilizing pharmacists for billable services related to disease state management. JAPhA Pract Innov. 2024; 1(1): 1–6. https://doi.org/10.1016/j.japhpi.2023.100006
10.1016/j.japhpi.2023.100006 Google Scholar
- 35Lapping AD, Carroll JC, Coley KC, Somma McGivney MA, Doong K, Antinopoulos B, et al. Implementation strategies from deployment of the National Diabetes Prevention Program in Pennsylvania community pharmacies. J Am Pharm Assoc. 2020; 60(3S): S29–S36.e1. https://doi.org/10.1016/j.japh.2020.01.010
10.1016/j.japh.2020.01.010 Google Scholar
- 36Ritchie ND, Baucom KJW, Sauder KA. Current perspectives on the impact of the National Diabetes Prevention Program: building on successes and overcoming challenges. Diabetes Metab Syndr Obes. 2020; 13: 2949–2957. https://doi.org/10.2147/DMSO.S218334
- 37Spence R, Sisson EM, Dixon DL. Survey of CDC-recognized community pharmacies providing the National Diabetes Prevention Program and impact of the COVID-19 pandemic on program delivery. J Am Pharm Assoc. 2022; 62(5): 1581–1586. https://doi.org/10.1016/j.japh.2022.03.020
- 38 American Pharmacists Association Foundation. National pharmacy diabetes prevention network: American Pharmacists Association Foundation umbrella hub arrangement spotlight. https://coveragetoolkit.org/wp-content/uploads/2024/05/NACDD-APhA-Foundation_Spotlight.pdf (2024). Accessed 27 Aug 2024
- 39Gawlik G, Nguyen E, Robinson R. Exploring barriers and facilitators to pharmacist-provided diabetes self-management education and support. J Am Pharm Assoc. 2023; 63(1): 74–79. https://doi.org/10.1016/j.japh.2022.08.003
- 40 Pharmacy Times. Provider status for pharmacists: it's about time. https://www.pharmacytimes.com/view/provider-status-for-pharmacists-its-about-time. Accessed 27 Aug 2024
- 41Trapskin K, Johnson C, Cory P, Sorum S, Decker C. Forging a novel provider and payer partnership in Wisconsin to compensate pharmacists for quality-driven pharmacy and medication therapy management services. J Am Pharm Assoc. 2009; 49(5): 642–651. https://doi.org/10.1331/JAPhA.2009.08158
- 42Pestka DL, Sorensen TD, Westberg SM. Building health plan-pharmacist provider partnerships to optimize medication outcomes. J Manag Care Spec Pharm. 2023; 29(12): 1284–1289. https://doi.org/10.18553/jmcp.2023.29.12.1284
- 43Al-Khatib A, Andreski M, Pudlo A, Doucette WR. An evaluation of community pharmacies' actions under value-based payment. J Am Pharm Assoc. 2020; 60(6): 899–905.e2. https://doi.org/10.1016/j.japh.2020.06.014
- 44Moore M, Jadallah J, Nadpara P, Goode J. Assessing willingness of patients with diabetes to attend pharmacist-led structured and patient specific diabetes self-management education. Innov Pharm. 2022; 13(1):4429. https://doi.org/10.24926/iip.v13i1.4429
10.24926/iip.v13i1.4429 Google Scholar